CRNX

NASDAQStock

Crinetics Pharmaceuticals, Inc.

$36.90-0.20 (-0.54%)

52-Week Range

$25.56
$56.43

Key Stats

Market Cap

3.9B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24

Volume

671.3K

Avg Volume

1.1M

Performance

1M

-23.31%

3M

-27.69%

6M

+8.11%

YTD

-21.87%

1Y

+3.14%

3Y

+104.54%

5Y

+115.91%

Price Chart

ETF Exposure

CRNX is held by 90 ETFs

ETFFund NameWeight
FYXFirst Trust Small Cap Core AlphaDEX Fund0.05%
AVIEAvantis Inflation Focused Equity ETF0.04%
FESMFIDELITY ENHANCED SMALL CAP ETF0.03%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.03%
WSMLiShares MSCI World Small-Cap ETF0.03%
SMMDiShares Russell 2500 ETF0.03%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.02%
FADFirst Trust Multi Cap Growth AlphaDEX Fund0.02%
HDGProShares - Hedge Replication ETF0.02%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
ESGVVanguard ESG U.S. Stock ETF0.01%
VTIVanguard Total Stock Market ETF0.01%
VTHRVanguard Russell 3000 ETF0.01%
DCORDimensional - US Core Equity 1 ETF0.01%
DFUSDimensional - US Equity Market ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.01%
IWViShares Russell 3000 ETF0.01%
SCHBSchwab U.S. Broad Market ETF0.01%
DFACDimensional - US Core Equity 2 ETF0.01%
DXUVDimensional - US Vector Equity ETF0.01%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.01%
DFAUDimensional - US Core Equity Market ETF0.00%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.00%
VTVanguard Total World Stock ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
PreviousPage 2 of 2

About CRNX ETF Exposure

Crinetics Pharmaceuticals, Inc. (CRNX) is held by 90 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.9B, CRNX is a widely held institutional stock. The stock currently trades at $36.90. Investors can gain exposure to CRNX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CRNX, sorted by portfolio weight.